Healthcare Global Enterprises Limited

rs,

Mumbai - 400051, Maharashtra, India BSE Limited, Compliance Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001, Maharashtra, India Dear Sir/Madam, Subject : Stock Code : BSE –

19%

V E N U E R E V E N U E - H C G C e n t e r s ( 1 ) R E V E N U E - M i l a n n C e n t e r s ^ +19% 4,247 3,581 +20% 3,412 4,080 168 167 -1% Q3FY22 Q3FY23 Q3FY22 Q3FY23 Q3FY22 Q3FY23 A

20%

U E - H C G C e n t e r s ( 1 ) R E V E N U E - M i l a n n C e n t e r s ^ +19% 4,247 3,581 +20% 3,412 4,080 168 167 -1% Q3FY22 Q3FY23 Q3FY22 Q3FY23 Q3FY22 Q3FY23 A D J U S T E D E B I

1%

) R E V E N U E - M i l a n n C e n t e r s ^ +19% 4,247 3,581 +20% 3,412 4,080 168 167 -1% Q3FY22 Q3FY23 Q3FY22 Q3FY23 Q3FY22 Q3FY23 A D J U S T E D E B I T D A A D J U S T E D E B I

28%

I T A F T E R TA X 2 ( P r e - I N D A S ) P R O F I T A F T E R TA X 2 ( P o s t - I N D A S ) +28% + 136 bps 812 17.8% 19.1% 636 +260% 113 31 Q3FY22 Q3FY23 Q3FY22 Q3FY23 Q3FY22 Q3FY23

136 bps

F T E R TA X 2 ( P r e - I N D A S ) P R O F I T A F T E R TA X 2 ( P o s t - I N D A S ) +28% + 136 bps 812 17.8% 19.1% 636 +260% 113 31 Q3FY22 Q3FY23 Q3FY22 Q3FY23 Q3FY22 Q3FY23 Adjusted

17.8%

( P r e - I N D A S ) P R O F I T A F T E R TA X 2 ( P o s t - I N D A S ) +28% + 136 bps 812 17.8% 19.1% 636 +260% 113 31 Q3FY22 Q3FY23 Q3FY22 Q3FY23 Q3FY22 Q3FY23 Adjusted EBIDTA exclud

19.1%

- I N D A S ) P R O F I T A F T E R TA X 2 ( P o s t - I N D A S ) +28% + 136 bps 812 17.8% 19.1% 636 +260% 113 31 Q3FY22 Q3FY23 Q3FY22 Q3FY23 Q3FY22 Q3FY23 Adjusted EBIDTA excludes - -

260%

) P R O F I T A F T E R TA X 2 ( P o s t - I N D A S ) +28% + 136 bps 812 17.8% 19.1% 636 +260% 113 31 Q3FY22 Q3FY23 Q3FY22 Q3FY23 Q3FY22 Q3FY23 Adjusted EBIDTA excludes - - Impact of

INR 17.94

Y22 Q3FY23 Q3FY22 Q3FY23 Q3FY22 Q3FY23 Adjusted EBIDTA excludes - - Impact of ESOPs cost of INR 17.94 mn for Q3FY23 and 17.29 mn in Q3FY22 Impact of one-time consulting fees for strategy work for a peri

INR 39

ing fees for strategy work for a period of 12-18 months. Cost of one-time consulting fees stands at INR 39 mn for Q3FY23 1. 2. 22 comprehensive cancer centers, 3 multispecialty hospitals PAT for Q3FY22 is

21%

V E N U E R E V E N U E - H C G C e n t e r s ( 1 ) R E V E N U E - M i l a n n C e n t e r s ^ +21% 12,527 10,332 +22% 12,022 9,869 +9% 463 505 9MFY22 9MFY23 9MFY22 9MFY23 9MFY22 9MFY23

“Although the Company believes that such forward ‐ looking statements are based on reasonable assumptions, it can give no assurance that such expectations will be met.”

“No Particulars Capex incurred till 31 st Dec 2022 Expected Capex between Jan 22 to Mar 23 Expected Capex for FY24 Total Planned Capex Expected date of Operations 1 2 Ahmedabad – Phase II Whitefield (Extension of Bangalore - COE) 84.0 10.0 132.2 40.0 635.8 200.0 852.0 250.0 Q1 FY25 Q4 FY24 1.”

Subject

1

Subject

Stock Code : BSE – 539787, NSE – HCG Investor Presentation We wish to inform you that the Board of Directors of the Company, at their meeting held on February 09, 2023, inter alia, has approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2022 (“Financial Results”). In this respect, we enclose herewith the Presentation on the Financial Results of the Company for the quarter and nine months ended December 31, 2022. Request you to take this on record. Thanking you, For HealthCare Global Enterprises Limited Sunu Manuel Company Secretary & Compliance Officer Encl: a/a. HealthCare Global Enterprises Limited HCG Tower, # 8, P Kalinga Rao Road, Sampangi Rama Nagar, Bangalore - 560027. 080 33669999 | info@hcgoncology.com | www.hcgoncology.com | CIN : L15200KA1998PLC023489 HEALTHCARE GLOBAL ENTERPRISES LIMITED INV E STOR P R E SE NTAT ION February 2023 SAFE HARBOR This presentation and its contents are confidenti